Association between airway inflammation, airway remodelling and physiological changes in asthma

R. Berair, S. Gonem, V. Mistry, A. Singapuri, N. Rana, R. Kay, S. Siddiqui, C. Brightling (Leicester, United Kingdom; Basel, Switzerland)

Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Session: New mechanisms in the pathogenesis of asthma and other lung diseases
Session type: Thematic Poster Session
Number: 3865
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

BackgroundIn asthma the association between airway inflammation, airway remodelling, determined in bronchial biopsies; and lung physiology is unclear.MethodsPatients with moderate-to-severe persistent asthma and sputum eosinophilia (>2%) underwent endobronchial sampling, spirometry, lung plethysmography and impulse oscillometry. Airway biopsies were examined for airway smooth muscle (ASM) content (ASM%), reticular basement membrane (RBM) thickness and inflammatory cells counts (cells/mm2 of submucosa) for eosinophils, T-lymphocytes, neutrophils and mast cells.Results34 patients were recruited. ASM% was negatively correlated with both pre-bronchodilator (rs= -0.446, p=0.008) and post-bronchodilator FEV₁/FVC and (rs= -0.445, p=0.008); but no correlation with oscillometry indices or inflammatory cell counts. RBM thickness did not correlate with submucosal inflammatory cell counts or physiological indices. Submucosal eosinophils were positively correlated with CO transfer coefficient (KCO) (rs= 0.381, p=0.026), and R5 (rs= 0.441, p=0.009).



Conclusion Increased ASM% and submucosal eosinophils were associated with airflow obstruction and resistance respectively. Whether resistance measures are a sensitive measure of response to anti-eosinophilic therapies requires further study.Acknowledgements: Work funded by Novartis Pharmaceuticals.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Berair, S. Gonem, V. Mistry, A. Singapuri, N. Rana, R. Kay, S. Siddiqui, C. Brightling (Leicester, United Kingdom; Basel, Switzerland). Association between airway inflammation, airway remodelling and physiological changes in asthma. Eur Respir J 2014; 44: Suppl. 58, 3865

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The airway microbiota is significantly altered in subjects with eosinophilic asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Airway remodeling and eosinophilic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

MIP-1β is associated with eosinophilic airway inflammation
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

The role of the KCa3.1 channel in the regulation of airway mucus hypersecretion in asthma
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014

Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


LATE-BREAKING ABSTRACT: Airway remodelling induced by ADAM33 is reversible
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Relationship between airway inflammation and bronchial responsiveness in children with and without asthma
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014


Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014


Altered airway microbiome in stable asthma
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014


Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Airway inflammation in patients with different levels of asthma control
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013


Small airways obstruction and asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Discrimination of bronchial inflammatory phenotype of asthmatic patients by using the electronic nose
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013



Omalizumab prevents smooth muscle cell growth induced by asthmatic serum
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014

Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014